Our mission is to define the signals that regulate normal and malignant hematopoiesis and to exploit this knowledge to develop new therapies for hematopoietic malignancies.

Our current research is focused on two general areas: characterizing the regulation of hematopoietic niches in the bone marrow under homeostatic and stress conditions and defining the molecular pathogenesis and treatment of leukemias.  Cutting edge genomic, transgenic, and imaging approaches are being used in this research.  The Link laboratory emphasizes a collaborative research environment and places a priority on the career development of its trainees.

Hematopoietic Niche
Leukemia Pathogenesis and Treatment

Current research reported on this website is supported by the National Cancer Institute and the National Heart, Lung, and Blood Institute of the National Institutes of Health. Advancements are also made possible thanks to support by The Henry and Marilyn Taub Foundation and Specialized Program of Research Excellence in Leukemia